These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38739968)

  • 1. Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.
    Dolezalova K; Hadlova P; Ibrahimova M; Golias J; Baca L; Kopecka E; Sukholytka M; Koziar Vasakova M
    Tuberculosis (Edinb); 2024 Jul; 147():102518. PubMed ID: 38739968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CD8
    Viana Machado F; Morais C; Santos S; Reis R
    Respir Med; 2021; 185():106508. PubMed ID: 34171790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
    Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
    J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
    Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
    Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
    Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
    Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
    Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
    Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
    Tuberculosis (Edinb); 2020 Jul; 123():101959. PubMed ID: 32741535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens.
    Yamashita Y; Hoshino Y; Oka M; Matsumoto S; Ariga H; Nagai H; Makino M; Ariyoshi K; Tsunetsugu-Yokota Y
    Jpn J Infect Dis; 2013; 66(3):207-15. PubMed ID: 23698481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.